|
1
|
Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis.
|
Med Princ Pract
|
2014
|
1.99
|
|
2
|
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms.
|
Brain
|
2009
|
1.89
|
|
3
|
VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena.
|
Brain
|
2004
|
1.67
|
|
4
|
The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.
|
FASEB J
|
2006
|
1.64
|
|
5
|
Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1.
|
Neurobiol Dis
|
2005
|
1.45
|
|
6
|
Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
|
FASEB J
|
2005
|
1.40
|
|
7
|
Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity.
|
Brain
|
2011
|
1.29
|
|
8
|
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.
|
Nat Neurosci
|
2006
|
1.10
|
|
9
|
c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
|
Circulation
|
2008
|
1.08
|
|
10
|
Role of Nogo-A in neuronal survival in the reperfused ischemic brain.
|
J Cereb Blood Flow Metab
|
2010
|
1.06
|
|
11
|
When melatonin gets on your nerves: its beneficial actions in experimental models of stroke.
|
Exp Biol Med (Maywood)
|
2005
|
1.06
|
|
12
|
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice.
|
J Pineal Res
|
2008
|
1.05
|
|
13
|
Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain.
|
Acta Neuropathol
|
2011
|
1.04
|
|
14
|
Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice.
|
Stroke
|
2006
|
0.94
|
|
15
|
ABCC1: a gateway for pharmacological compounds to the ischaemic brain.
|
Brain
|
2008
|
0.93
|
|
16
|
Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
|
Stroke
|
2004
|
0.91
|
|
17
|
Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.
|
J Pineal Res
|
2004
|
0.89
|
|
18
|
Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions.
|
Neurobiol Dis
|
2011
|
0.89
|
|
19
|
Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain.
|
J Neurosci
|
2008
|
0.89
|
|
20
|
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
|
Pol J Pharmacol
|
2004
|
0.88
|
|
21
|
Rifampicin attenuates brain damage in focal ischemia.
|
Brain Res
|
2004
|
0.87
|
|
22
|
Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.
|
J Pineal Res
|
2005
|
0.87
|
|
23
|
Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator.
|
J Pineal Res
|
2004
|
0.84
|
|
24
|
TAT fusion proteins against ischemic stroke: current status and future perspectives.
|
Front Biosci
|
2006
|
0.83
|
|
25
|
TAT-GDNF in neurodegeneration and ischemic stroke.
|
CNS Drug Rev
|
2005
|
0.80
|
|
26
|
Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo.
|
Neurodegener Dis
|
2005
|
0.80
|
|
27
|
Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice.
|
Neurobiol Dis
|
2002
|
0.78
|
|
28
|
Intravenously administered recombinant tissue-plasminogen activator attenuates neuronal injury after mild focal cerebral ischemia in mice.
|
Neuroreport
|
2004
|
0.78
|
|
29
|
Poxvirus-derived cytokine response modifier A (CrmA) does not protect against focal cerebral ischemia in mice.
|
Brain Res
|
2007
|
0.77
|
|
30
|
Melatonin attenuates phenytoin sodium-induced DNA damage.
|
Drug Chem Toxicol
|
2013
|
0.76
|
|
31
|
Reply. Paraoxonase: A Multifunctional Biomolecule.
|
Med Princ Pract
|
2015
|
0.75
|
|
32
|
Erythropoietin receptor-like immunostaining on human spermatozoa.
|
Reprod Biomed Online
|
2010
|
0.75
|
|
33
|
Does erythropoietin affect motility of spermatozoa?
|
Arch Gynecol Obstet
|
2009
|
0.75
|
|
34
|
A novel non-surgical, minimally invasive technique for parathyroid autotransplantation: a case report.
|
Pediatr Transplant
|
2014
|
0.75
|
|
35
|
GAS6 intron 8 c.834 + 7G > A gene polymorphism in diabetic nephropathy.
|
Ren Fail
|
2015
|
0.75
|
|
36
|
Parathyroid Allotransplant for Persistent Hypocalcaemia: A New Technique Involving Short-Term Culture.
|
Exp Clin Transplant
|
2014
|
0.75
|